OAKLAND, CA –- Gibbs Law Group has filed a federal lawsuit against Sanofi-Aventis alleging that the company failed to warn breast cancer patients that they may experience permanent, disfiguring hair loss, or alopecia, following the use of its Taxotere (docetaxel) chemotherapy product.
The complaint alleges that the defendants were aware, based on multiple studies and physician’s reports, that patients who took Taxotere could experience permanent disfiguring hair loss, and that the company warned doctors, patients, and regulatory agencies in other countries of the risk, but withheld the information from patients and doctors in the United States. The complaint also alleges that Sanofi-Aventis did not inform women that they had an alternative option to treat with Taxol, a less potent and equally effective chemotherapy drug.
Individuals who suffer from permanent alopecia or hair loss after receiving Taxotere and would like to learn more about our Taxotere hair loss lawsuit and their legal rights may contact Gibbs Law Group at (800) 254-9493. Our attorneys pride themselves on being there for our clients at every stage of the litigation, from intake through verdict or settlement.
Our attorneys have more than twenty years of experience successfully representing people injured by some of the nation’s largest and most powerful corporations. We have recovered millions of dollars on behalf of injured clients in litigation against drug manufacturers.
Lead attorney Karen Barth Menzies has over two decades of experience representing clients in pharmaceutical injury lawsuits, with a particular focus on litigation concerning women’s health. She has been appointed by courts throughout the country to serve in leadership positions in some of the largest pharmaceutical personal injury cases, and has testified before FDA advisory boards as well as the California State Legislature on drug safety issues and manufacturer misconduct.
Our firm is currently litigating a number of cases involving women’s health issues, including lawsuits on behalf of women injured by Essure permanent birth control. We have previously represented women in lawsuits involving Yaz birth control, transvaginal mesh, and Mirena.